| Filed On | Filing |
|---|---|
| 14 Dec 2023 |
8-K/A: Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure
Further establishes Pfizer as a leading oncology company poised to accelerate the next generation of breakthrough treatments for people with cancer |
| 21 Dec 2017 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 14 Nov 2016 | 8-K/A: Other Events |
| 30 Jun 2003 | 8-K/A: Completion of Acquisition or Disposition of Assets |
| 28 Apr 2003 | 8-K/A: Changes in Registrant's Certifying Accountant |
| 10 May 1995 | 8-K/A: Financial Statements and Exhibits |
Loading...
